tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Vera Therapeutics price target raised to $95 from $55 at Goldman Sachs
PremiumThe FlyVera Therapeutics price target raised to $95 from $55 at Goldman Sachs
23d ago
Vera Therapeutics price target lowered to $96 from $99 at JPMorgan
Premium
The Fly
Vera Therapeutics price target lowered to $96 from $99 at JPMorgan
23d ago
Vera Therapeutics: Reinforced Buy on Atacicept’s Leading IgAN Profile, Robust Cash Runway, and Expanded Peak Sales Potential
Premium
Ratings
Vera Therapeutics: Reinforced Buy on Atacicept’s Leading IgAN Profile, Robust Cash Runway, and Expanded Peak Sales Potential
23d ago
Vera Therapeutics 6.14M share Secondary priced at $42.50
PremiumThe FlyVera Therapeutics 6.14M share Secondary priced at $42.50
1M ago
Vera Therapeutics offers to sell up to $200M in common stock
Premium
The Fly
Vera Therapeutics offers to sell up to $200M in common stock
1M ago
Vera Therapeutics price target raised to $97 from $75 at Evercore ISI
Premium
The Fly
Vera Therapeutics price target raised to $97 from $75 at Evercore ISI
1M ago
Vera Therapeutics rises 19.2%
PremiumThe FlyVera Therapeutics rises 19.2%
1M ago
These 3 Stocks Have Triple-Digit Upside Potential, Say Five-Star Analysts – 11/26/2025
Premium
Market News
These 3 Stocks Have Triple-Digit Upside Potential, Say Five-Star Analysts – 11/26/2025
2M ago
Vera Therapeutics Appoints James R. Meyers to Board
Premium
Company Announcements
Vera Therapeutics Appoints James R. Meyers to Board
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100